諾華公司 - 存託憑證（普通股）
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionBDO Wealth Advisors, LLC
Latest Disclosed Ownership6,146 shares
Latest Disclosed Value $ 620,236
BDO Wealth Advisors, LLC reports 1.42% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On August 1, 2023 - BDO Wealth Advisors, LLC filed a 13F-HR form disclosing ownership of 6,146 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $620,193 USD as of June 30, 2023. The entity filed a previous 13F-HR on May 9, 2023 disclosing 6,060 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 1.42% during the quarter. The current value of the position is $916,737 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2023-08-01 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,146 86 1.42 620 11.31 0.0711
2023-05-09 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,060 -453 -6.96 558 -5.59 0.0684
2023-01-30 2022-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 6,513 645 10.99 591 32.29 0.0734
2023-01-27 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,513 645 591 0.0001
2022-11-02 2022-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 5,868 325 5.86 446 -4.90 0.0593
2022-11-01 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 5,543 0 469 0.0576
2022-08-25 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 5,543 -149 -2.62 469 -6.01 0.0577
2022-05-06 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 5,692 -275 -4.61 499 -4.41 0.0532
2022-02-11 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 5,967 -601 -9.15 522 -2.79 0.0552
2021-11-09 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,568 -657 -9.09 537 -18.51 0.0591
2021-09-03 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,225 3,061 73.51 659 85.11 0.0730
2021-05-14 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,164 -879 -17.43 356 -25.21 0.0420
2021-02-12 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 5,043 38 0.76 476 9.43 0.0670
2020-11-12 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 5,005 -3 -0.06 435 -0.46 0.0708
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 5,008 138 2.83 437 8.71 0.0768
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 4,870 1,049 27.45 402 11.05 0.0812
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,821 207 5.73 362 15.29 0.0934
2019-11-12 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,614 -195 -5.12 314 -9.77 0.0804
2019-08-09 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,809 842 28.38 348 22.11 0.0948
2019-05-15 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,967 701 30.94 285 46.91 0.0828
2019-02-14 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,266 787 53.21 194 52.76 0.0668
2018-11-07 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,479 100 7.25 127 22.12 0.0410
2018-08-27 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,379 114 9.01 104 1.96 0.0354
2018-05-23 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,265 395 45.40 102 39.73 0.0383
2018-02-14 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 870 100 12.99 73 10.61 0.0328
2017-11-08 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 770 320 71.11 66 73.68 0.0327
2017-08-07 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 450 450 38 0.0166
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.